Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-07-28

Clinical Trial Update: The Pathophysiology of Bortezomib Induced Peripheral Neuropathy

View source ↗

Summary

An update on the pathophysiology of bortezomib-induced peripheral neuropathy in patients with multiple myeloma, outlining the mechanisms of nerve damage associa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bortezomib (bortezomib)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Multiple Myeloma | Status: UNKNOWN